Pretransplant Sensitization Against Angiotensin II Type 1 Receptor Is a Risk Factor for Acute Rejection and Graft Loss
Giral et al., American Journal of Transplantation, 2013
Angiotensin Antibodies and Focal Segmental Glomerulosclerosis
Alachkar et al., N Eng J Med, 2013
Consensus guidelines on the testing and clinical management issues associated with HLA and Non-HLA antibodies in transplantation.
Tait et al., Transplantation 2013
Renal ischemia and transplantation predispose to vascular constriction mediated by angiotensin II type 1 receptor-activating antibodies.
Lukitsch et al., Transplantation, 2012
Non-HLA-antibodies targeting Angiotensin type 1 receptor and antibody mediated rejection.
Dragun et al., Human Immunology, 2012
Non-HLA Antibodies Targeting Vascular Receptors Enhance Alloimmune Response and Microvasculopathy After Heart Transplantation.
Hiemann et al., Transplantation, 2012
Activating autoantibodies against the AT1-receptor in vascular disease
Dechend et al., Transplantation, 2012
Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients.
Reinsmoen et al., Transplantation, 2010
Complement-binding anti-HLA antibodies and kidney-allograft survival.
Loupy A, N Engl J Med., 2013
Common and well-documented HLA alleles: 2012 update to the CWD catalogue.
Mack SJ, Tissue Antigens., 2013